2018-2023 Global Peripheral Intervention Drug-Eluting Devices Consumption Market Report
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Peripheral Intervention Drug-Eluting Devices market for 2018-2023.
Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
Over the next five years, LPI(LP Information) projects that Peripheral Intervention Drug-Eluting Devices will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Intervention Drug-Eluting Devices market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)
Segmentation by application:
Drug-Eluting Balloons
Drug-Eluting Stents
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
St. Jude Medical, Inc.
The Lubrizol Corporation
Terumo Corporation
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Peripheral Intervention Drug-Eluting Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Peripheral Intervention Drug-Eluting Devices market by identifying its various subsegments.
Focuses on the key global Peripheral Intervention Drug-Eluting Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Peripheral Intervention Drug-Eluting Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Peripheral Intervention Drug-Eluting Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2018-2023 Global Peripheral Intervention Drug-Eluting Devices Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peripheral Intervention Drug-Eluting Devices Consumption 2013-2023
2.1.2 Peripheral Intervention Drug-Eluting Devices Consumption CAGR by Region
2.2 Peripheral Intervention Drug-Eluting Devices Segment by Type
2.2.1 Plain Old Balloon Angioplasty (POBA)
2.2.2 Percutaneous Transluminal Angioplasty (PTA)
2.3 Peripheral Intervention Drug-Eluting Devices Consumption by Type
2.3.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Type (2013-2018)
2.3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Type (2013-2018)
2.3.3 Global Peripheral Intervention Drug-Eluting Devices Sale Price by Type (2013-2018)
2.4 Peripheral Intervention Drug-Eluting Devices Segment by Application
2.4.1 Drug-Eluting Balloons
2.4.2 Drug-Eluting Stents
2.5 Peripheral Intervention Drug-Eluting Devices Consumption by Application
2.5.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application (2013-2018)
2.5.2 Global Peripheral Intervention Drug-Eluting Devices Value and Market Share by Application (2013-2018)
2.5.3 Global Peripheral Intervention Drug-Eluting Devices Sale Price by Application (2013-2018)
3 Global Peripheral Intervention Drug-Eluting Devices by Players
3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Players
3.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Players (2016-2018)
3.1.2 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Players (2016-2018)
3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Players
3.2.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Players (2016-2018)
3.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Players (2016-2018)
3.3 Global Peripheral Intervention Drug-Eluting Devices Sale Price by Players
3.4 Global Peripheral Intervention Drug-Eluting Devices Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Peripheral Intervention Drug-Eluting Devices Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Peripheral Intervention Drug-Eluting Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Peripheral Intervention Drug-Eluting Devices by Regions
4.1 Peripheral Intervention Drug-Eluting Devices by Regions
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Consumption by Regions
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Value by Regions
4.2 Americas Peripheral Intervention Drug-Eluting Devices Consumption Growth
4.3 APAC Peripheral Intervention Drug-Eluting Devices Consumption Growth
4.4 Europe Peripheral Intervention Drug-Eluting Devices Consumption Growth
4.5 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Growth
5 Americas
5.1 Americas Peripheral Intervention Drug-Eluting Devices Consumption by Countries
5.1.1 Americas Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2013-2018)
5.1.2 Americas Peripheral Intervention Drug-Eluting Devices Value by Countries (2013-2018)
5.2 Americas Peripheral Intervention Drug-Eluting Devices Consumption by Type
5.3 Americas Peripheral Intervention Drug-Eluting Devices Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Peripheral Intervention Drug-Eluting Devices Consumption by Countries
6.1.1 APAC Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2013-2018)
6.1.2 APAC Peripheral Intervention Drug-Eluting Devices Value by Countries (2013-2018)
6.2 APAC Peripheral Intervention Drug-Eluting Devices Consumption by Type
6.3 APAC Peripheral Intervention Drug-Eluting Devices Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Peripheral Intervention Drug-Eluting Devices by Countries
7.1.1 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2013-2018)
7.1.2 Europe Peripheral Intervention Drug-Eluting Devices Value by Countries (2013-2018)
7.2 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Type
7.3 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices by Countries
8.1.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Value by Countries (2013-2018)
8.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption by Type
8.3 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Peripheral Intervention Drug-Eluting Devices Distributors
10.3 Peripheral Intervention Drug-Eluting Devices Customer
11 Global Peripheral Intervention Drug-Eluting Devices Market Forecast
11.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2018-2023)
11.2 Global Peripheral Intervention Drug-Eluting Devices Forecast by Regions
11.2.1 Global Peripheral Intervention Drug-Eluting Devices Forecast by Regions (2018-2023)
11.2.2 Global Peripheral Intervention Drug-Eluting Devices Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Peripheral Intervention Drug-Eluting Devices Forecast by Type
11.8 Global Peripheral Intervention Drug-Eluting Devices Forecast by Application
12 Key Players Analysis
12.1 Medtronic plc
12.1.1 Company Details
12.1.2 Peripheral Intervention Drug-Eluting Devices Product Offered
12.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Medtronic plc News
12.2 Boston Scientific Corporation
12.2.1 Company Details
12.2.2 Peripheral Intervention Drug-Eluting Devices Product Offered
12.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Boston Scientific Corporation News
12.3 Abbott Laboratories
12.3.1 Company Details
12.3.2 Peripheral Intervention Drug-Eluting Devices Product Offered
12.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Abbott Laboratories News
12.4 Cardinal Health
12.4.1 Company Details
12.4.2 Peripheral Intervention Drug-Eluting Devices Product Offered
12.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Cardinal Health News
12.5 B. Braun Melsungen AG
12.5.1 Company Details
12.5.2 Peripheral Intervention Drug-Eluting Devices Product Offered
12.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 B. Braun Melsungen AG News
12.6 Biosensors International Group Ltd.
12.6.1 Company Details
12.6.2 Peripheral Intervention Drug-Eluting Devices Product Offered
12.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Biosensors International Group Ltd. News
12.7 C.R. Bard, Inc.
12.7.1 Company Details
12.7.2 Peripheral Intervention Drug-Eluting Devices Product Offered
12.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 C.R. Bard, Inc. News
12.8 St. Jude Medical, Inc.
12.8.1 Company Details
12.8.2 Peripheral Intervention Drug-Eluting Devices Product Offered
12.8.3 St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 St. Jude Medical, Inc. News
12.9 The Lubrizol Corporation
12.9.1 Company Details
12.9.2 Peripheral Intervention Drug-Eluting Devices Product Offered
12.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 The Lubrizol Corporation News
12.10 Terumo Corporation
12.10.1 Company Details
12.10.2 Peripheral Intervention Drug-Eluting Devices Product Offered
12.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Terumo Corporation News
13 Research Findings and Conclusion
